- Home
- APTV
APTV
Aptiv PLC
as 01-17-2025 4:00pm EST
Aptiv Holdings Ltd, formerly Aptiv PLC signal and power solutions segment supplies components and systems that make up a vehicle's electrical system, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, driver-assist technologies, and displays, as well as the development of software for these systems.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 14.1B | IPO Year: | 1999 |
| Target Price: | $84.00 | AVG Volume (30 days): | 3.7M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 9.04 | EPS Growth: | 11.88 |
| 52 Week Low/High: | $51.47 - $88.89 | Next Earning Date: | 02-06-2025 |
| Revenue: | $19,725,000,000 | Revenue Growth: | -0.24% |
| Revenue Growth (this year): | 0.2% | Revenue Growth (next year): | 2.69% |
Latest Aptiv PLC News
APTV Breaking Stock News: Dive into APTV Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Here's Why You Should Retain Aptiv Stock in Your Portfolio Now
MT Newswires
4 days ago
Baird Adjusts Aptiv Price Target to $70 From $65, Maintains Neutral Rating
Zacks
4 days ago
Aptiv PLC (APTV) Is a Trending Stock: Facts to Know Before Betting on It
MT Newswires
5 days ago
UBS Adjusts Price Target on Aptiv to $73 From $75, Keeps Buy Rating
MT Newswires
5 days ago
Goldman Sachs Trims Aptiv Price Target to $70 From $71, Maintains Buy Rating
Zacks
6 days ago
Aptiv PLC (APTV) Stock Sinks As Market Gains: Here's Why
Argus Research
6 days ago
APTV: What does Argus have to say about APTV?
Zacks
6 days ago
Aptiv PLC (APTV) Exceeds Market Returns: Some Facts to Consider
Compare APTV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APTV Aptiv PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.